乳腺外科研究的机遇与优先方向
本文通过召集活跃于研究的乳腺外科医生,按患者诊疗路径梳理乳腺外科研究领域,包括诊断、新辅助治疗、手术、辅助治疗及特殊人群,并经与相关学会和患者组织咨询后迭代修改,明确关键研究空白并提出解决策略。
要点
- 关键研究空白包括过度诊断与过度治疗、新辅助治疗及后续手术选择优化、降低保乳再手术率。
- 需生成乳房重建临床有效性与成本效果证据,并建立评估新干预的机制。
- 应确立最佳腋窝管理(尤其新辅助治疗后)及风险降低手术的标准化指征。
核心结论
- 外科医生应在乳腺癌研究中发挥核心作用,培育参与研究的文化以使患者和医疗系统获益。
- 需发展基础设施与外科研究能力并合理分配研究资金,以在未来二十年内解决本文强调的关键临床与转化研究空白。
研究设计与样本
- 本文为综述,通过研究活跃的乳腺外科医生会议按患者诊疗路径识别研究领域,并由领域负责人邀请专家输入。
- 过程包括与Association of Breast Surgery及Independent Cancer Patients' Voice成员咨询,并迭代修改文件直至关键优先事项明确。
主要发现
- 关键研究空白涉及过度诊断与治疗相关问题。
- 需优化新辅助治疗及后续手术的治疗选择。
- 需降低保乳手术再手术率。
- 需生成乳房重建临床有效性与成本效果证据及新干预评估机制。
- 需确立最佳腋窝管理(尤其新辅助治疗后)及风险降低手术的标准化指征。
临床怎么用
- 乳腺外科医生应积极参与研究并推动研究文化建设。
- 临床应关注并针对过度诊断、保乳再手术、腋窝管理及风险降低手术指征等空白开展研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The 2013 Breast Cancer Campaign gap analysis established breast cancer research priorities without a specific focus on surgical research or the role of surgeons on breast cancer research. This Review aims to identify opportunities and priorities for research in breast surgery to complement the 2013 gap analysis. To identify these goals, research-active breast surgeons met and identified areas for breast surgery research that mapped to the patient pathway. Areas included diagnosis, neoadjuvant treatment, surgery, adjuvant therapy, and attention to special groups (eg, those receiving risk-reducing surgery). Section leads were identified based on research interests, with invited input from experts in specific areas, supported by consultation with members of the Association of Breast Surgery and Independent Cancer Patients' Voice groups. The document was iteratively modified until participants were satisfied that key priorities for surgical research were clear. Key research gaps included issues surrounding overdiagnosis and treatment; optimising treatment options and their selection for neoadjuvant therapies and subsequent surgery; reducing rates of re-operations for breast-conserving surgery; generating evidence for clinical effectiveness and cost-effectiveness of breast reconstruction, and mechanisms for assessing novel interventions; establishing optimal axillary management, especially post-neoadjuvant treatment; and defining and standardising indications for risk-reducing surgery. We propose strategies for resolving these knowledge gaps. Surgeons are ideally placed for a central role in breast cancer research and should foster a culture of engagement and participation in research to benefit patients and health-care systems. Development of infrastructure and surgical research capacity, together with appropriate allocation of research funding, is needed to successfully address the key clinical and translational research gaps that are highlighted in this Review within the next two decades.
引用
- Cutress RI, McIntosh SA, Potter S, et al. Opportunities and priorities for breast surgical research. Lancet Oncol. 2018. PMID: 30303126. doi:10.1016/S1470-2045(18)30511-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。